| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |